Meglu ER Tablet 1000 mg contains Metformin Hydrochloride, an extended-release oral antihyperglycemic agent widely used in the management of type 2 diabetes mellitus. Metformin belongs to the biguanide class of medications and works by reducing hepatic glucose production and enhancing insulin sensitivity in peripheral tissues such as muscle and fat.

The extended-release (ER) formulation of Meglu ensures a gradual release of metformin over 12–24 hours, providing stable blood glucose control throughout the day. This formulation helps minimize gastrointestinal side effects such as nausea, diarrhea, and abdominal discomfort that can occur with immediate-release metformin. Meglu ER 1000 mg is ideal for patients who require high-dose therapy or simplified once-daily dosing, improving adherence and long-term glycemic control.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Meglu ER Tablet 1000 mg is indicated for:

• Type 2 diabetes mellitus in adults and adolescents (≥10 years) to improve glycemic control

• Monotherapy in patients not adequately controlled with diet and exercise alone

• Combination therapy with other oral antidiabetic agents or insulin when monotherapy is insufficient

• Management of insulin resistance-related metabolic disorders

• Prevention of type 2 diabetes in high-risk individuals under medical supervision

Meglu ER helps control fasting and postprandial blood glucose levels, supports weight management, and reduces the risk of long-term diabetes complications such as cardiovascular disease, nephropathy, and neuropathy.

Dosage and Administration

Recommended dosage:

• Adults: Typically 1000 mg once daily with the main meal, or as prescribed by a healthcare professional

• Maximum daily dose: 2,000–2,500 mg, divided into 1–2 ER tablets depending on clinical response

• Pediatric patients: Dose should be individualized based on age, weight, and physician guidance

Administration guidelines:

• Swallow the tablet whole; do not crush, chew, or break, as this may compromise the extended-release mechanism

• Take with the main meal to enhance absorption and reduce gastrointestinal discomfort

• Maintain a consistent daily schedule to ensure stable blood sugar levels

• Regular blood glucose monitoring is recommended to assess efficacy

Precautions and Warnings

• Lactic acidosis: Rare but serious; risk increases in patients with renal impairment, liver disease, severe infections, dehydration, or excessive alcohol consumption

• Renal function monitoring: Use cautiously in patients with moderate renal impairment; contraindicated in severe renal disease

• Hepatic caution: Careful use is advised in patients with liver dysfunction

• Contrast media: Temporary discontinuation may be required before iodinated contrast studies to prevent renal complications

• Pregnancy and breastfeeding: Generally considered safe under medical supervision; consult a healthcare provider

• Drug interactions: Certain medications such as diuretics, corticosteroids, and cationic drugs may affect blood glucose levels

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Meglu ER Tablet 1000 mg is generally well tolerated. Common side effects may include:

• Gastrointestinal disturbances: nausea, diarrhea, bloating, and abdominal discomfort

• Mild metallic taste in the mouth

• Rarely, long-term use may lead to vitamin B12 deficiency

Most side effects are mild and transient. Severe reactions, including lactic acidosis, are extremely rare but require immediate medical attention.

Storage

Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep tablets in their original packaging and out of reach of children.

Meglu ER Tablet 1000 mg (Metformin Hydrochloride) provides effective, long-acting glycemic control, minimizing side effects and offering convenient once-daily dosing. It is an ideal choice for patients with type 2 diabetes seeking consistent blood sugar management and improved adherence to therapy.